Organic compounds

The invention describes novel pharmaceutically acceptable salt forms of camostat, processes for lyophilisation, taste-masked formulations, nebulised formulations and the use of each of the fore-going in the treatment of respiratory diseases, particularly cystic fibrosis and chronic obstructive pulmo...

Full description

Saved in:
Bibliographic Details
Main Authors SINGH, DILRAJ, MAAS, JANET C, HARRIS, JENNIFER LESLIE, MONNIER, STEPHANIE, HEUERDING, SILVIA, REBER, JEAN-LOUIS, ROETTELE, JUERGEN, TULLY, DAVID C, DANAHAY, HENRY L, LEGRAND, DARREN M
Format Patent
LanguageEnglish
French
German
Published 06.04.2011
Subjects
ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract The invention describes novel pharmaceutically acceptable salt forms of camostat, processes for lyophilisation, taste-masked formulations, nebulised formulations and the use of each of the fore-going in the treatment of respiratory diseases, particularly cystic fibrosis and chronic obstructive pulmonary disease (COPD).
AbstractList The invention describes novel pharmaceutically acceptable salt forms of camostat, processes for lyophilisation, taste-masked formulations, nebulised formulations and the use of each of the fore-going in the treatment of respiratory diseases, particularly cystic fibrosis and chronic obstructive pulmonary disease (COPD).
Author TULLY, DAVID C
REBER, JEAN-LOUIS
HARRIS, JENNIFER LESLIE
ROETTELE, JUERGEN
DANAHAY, HENRY L
LEGRAND, DARREN M
HEUERDING, SILVIA
MONNIER, STEPHANIE
SINGH, DILRAJ
MAAS, JANET C
Author_xml – fullname: SINGH, DILRAJ
– fullname: MAAS, JANET C
– fullname: HARRIS, JENNIFER LESLIE
– fullname: MONNIER, STEPHANIE
– fullname: HEUERDING, SILVIA
– fullname: REBER, JEAN-LOUIS
– fullname: ROETTELE, JUERGEN
– fullname: TULLY, DAVID C
– fullname: DANAHAY, HENRY L
– fullname: LEGRAND, DARREN M
BookMark eNrjYmDJy89L5WQQ9C9KT8zLTFZIzs8tyC_NSynmYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxrgFGxgamZsaWjkbGRCgBAFvEIRM
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate COMPOSES ORGANIQUES
ORGANISCHE VERBINDUNGEN
ExternalDocumentID EP2305639A2
GroupedDBID EVB
ID FETCH-epo_espacenet_EP2305639A23
IEDL.DBID EVB
IngestDate Fri Jul 19 14:48:12 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
German
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_EP2305639A23
Notes Application Number: EP20100184992
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20110406&DB=EPODOC&CC=EP&NR=2305639A2
ParticipantIDs epo_espacenet_EP2305639A2
PublicationCentury 2000
PublicationDate 20110406
PublicationDateYYYYMMDD 2011-04-06
PublicationDate_xml – month: 04
  year: 2011
  text: 20110406
  day: 06
PublicationDecade 2010
PublicationYear 2011
RelatedCompanies IRM LLC
NOVARTIS PHARMA GMBH
NOVARTIS AG
RelatedCompanies_xml – name: IRM LLC
– name: NOVARTIS PHARMA GMBH
– name: NOVARTIS AG
Score 2.7946866
Snippet The invention describes novel pharmaceutically acceptable salt forms of camostat, processes for lyophilisation, taste-masked formulations, nebulised...
SourceID epo
SourceType Open Access Repository
SubjectTerms ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title Organic compounds
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20110406&DB=EPODOC&locale=&CC=EP&NR=2305639A2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1NS8Mw9DGmqLc5FTc_6EF6C8426dZDEZe2DGFbkSm7jaRJYZdt2Mr-vi_ZOr3o7ZHAIw_eV94nwIMvfS1EkZOQSUaoKjQRijIiPPlEZREgk5iM7ngSjN7p65zNG7Cse2HsnNCtHY6IEpWjvFdWX29-glixra0sH-USj9bP6SyKXVWH-5AnAzceRkk2jafc5Rwhd_IWecZV9sMX1NZHxos2Y_aTj6FpStn8tihpC44zRLaqzqGhV2045fXitTacjPf5bgT3oldeQGvXNZk7pgjc7EIqL8FJkxkfEcS9ONCxSLLDK_wraOL3Xl-D0-v3Q0ElWkohKFMDKZhmeeEJM3ieDVQHOn-i6f5zdwNnu_gnJb3gFprV55e-QwNayXtL-jfrPHRm
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1NT4Mw9GWZxnmbU-P85GC4ESe0MA7EOD6COhgxaHYjLZRkl20RjH_fVzamF729tMlL27yvvk-AW4MbgrEy12zKqUaKUmisIFRjOr8nvDSRSGREN4rN8I08z-m8A4u2FqbpE_rVNEdEjsqR3-tGXq9_nFhek1tZ3fEFLq0egtTx1KJ19yFNmqo3cfxk5s1c1XURUuNXR5emsmE_orTes2RzXmk5vU9kUcr6t0YJ-rCfILJlfQQdsRxAz20Hrw3gINrGuxHcsl51DP1N1WSuyCRwOQupOgEl8FM31BB3trtH5ie7Uxin0MXvvTgDZWRZNiMcNSVjhBZjzqigeakz2XiejoshDP9Ec_7P3g30wjSaZtOn-OUCDje-UKKNzEvo1h-f4gqVac2vm2f4BoR8d1M
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Organic+compounds&rft.inventor=SINGH%2C+DILRAJ&rft.inventor=MAAS%2C+JANET+C&rft.inventor=HARRIS%2C+JENNIFER+LESLIE&rft.inventor=MONNIER%2C+STEPHANIE&rft.inventor=HEUERDING%2C+SILVIA&rft.inventor=REBER%2C+JEAN-LOUIS&rft.inventor=ROETTELE%2C+JUERGEN&rft.inventor=TULLY%2C+DAVID+C&rft.inventor=DANAHAY%2C+HENRY+L&rft.inventor=LEGRAND%2C+DARREN+M&rft.date=2011-04-06&rft.externalDBID=A2&rft.externalDocID=EP2305639A2